Literature DB >> 17398231

Coronary ischemic events after first atrial fibrillation: risk and survival.

Yoko Miyasaka1, Marion E Barnes, Bernard J Gersh, Stephen S Cha, Kent R Bailey, James B Seward, Toshiji Iwasaka, Teresa S M Tsang.   

Abstract

PURPOSE: We aimed to determine the long-term, gender-specific incidence and mortality risk of coronary ischemic events after first atrial fibrillation (AF).
METHODS: In this longitudinal cohort study, adult residents of Olmsted County, Minnesota, with an electrocardiogram-confirmed AF first documented in 1980 to 2000 and without prior coronary heart disease, were followed to 2004. The primary outcome was first coronary events (angina with angiographic confirmation, unstable angina, nonfatal myocardial infarction, or coronary death). Sex-specific incidence of coronary ischemic events and survival after development of such events were assessed using Cox proportional hazards modeling. Kaplan-Meier estimates of risks for coronary ischemic events were compared with those predicted by the Framingham equation.
RESULTS: Of the 2768 subjects (mean age 71 years, 48% were men), 463 (17%) had a first coronary event during a follow-up of 6.0+/-5.2 years. The unadjusted incidence was 31 per 1000 person-years, and there was no difference between men and women. The incidence was higher in men (hazard ratio 1.32, P=.004) after adjusting for age. The 10-year event estimates were 22% and 19% in men and women, respectively, by our Kaplan-Meier analyses, and 21% and 11%, respectively, by Framingham risk equation. The mortality risk after coronary events was higher in women (hazard ratio 2.99 vs 2.33; P=.044), even after multiple adjustment.
CONCLUSIONS: First AF marks a high risk for new coronary ischemic events in both men and women. AF conferred additional risk for coronary events beyond conventional risk prediction in women only. The excess mortality risk associated with the development of coronary events was significantly greater in women.

Entities:  

Mesh:

Year:  2007        PMID: 17398231     DOI: 10.1016/j.amjmed.2006.06.042

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  24 in total

Review 1.  Management of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting: Review of the Literature.

Authors:  Ali J Khiabani; Taylan Adademir; Richard B Schuessler; Spencer J Melby; Marc R Moon; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2018 Nov/Dec

2.  The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue.

Authors:  Licia Polimeni; Ludovica Perri; Mirella Saliola; Stefania Basili; Francesco Violi
Journal:  Intern Emerg Med       Date:  2010-03-03       Impact factor: 3.397

3.  Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs.

Authors:  A Bukowska; M Hammwöhner; A Sixdorf; L Schild; I Wiswedel; F-W Röhl; C Wolke; U Lendeckel; C Aderkast; S Bochmann; R K Chilukoti; J Mostertz; P Bramlage; A Goette
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 4.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

5.  A double-blind, randomised, placebo-controlled, cross-over study assessing the use of XEN-D0103 in patients with paroxysmal atrial fibrillation and implanted pacemakers allowing continuous beat-to-beat monitoring of drug efficacy.

Authors:  S R Shunmugam; Conn Sugihara; Nick Freemantle; Patrick Round; Steve Furniss; Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2018-02-19       Impact factor: 1.900

6.  Screening For Atrial Fibrillation In The Community Using A Novel ECG Recorder.

Authors:  Irma Battipaglia; Katrina Gilbert; Andrew J Hogarth; Muzahir H Tayebjee
Journal:  J Atr Fibrillation       Date:  2016-08-31

7.  A cardiovascular disease risk prediction algorithm for use with the Medicare current beneficiary survey.

Authors:  Hassan Fouayzi; Arlene S Ash; Amy K Rosen
Journal:  Health Serv Res       Date:  2020-04-14       Impact factor: 3.402

Review 8.  Pathophysiology of concomitant atrial fibrillation and heart failure: implications for management.

Authors:  T Ben Morrison; T Jared Bunch; Bernard J Gersh
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-02

9.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.

Authors:  Renate B Schnabel; Lisa M Sullivan; Daniel Levy; Michael J Pencina; Joseph M Massaro; Ralph B D'Agostino; Christopher Newton-Cheh; Jennifer F Yamamoto; Jared W Magnani; Thomas M Tadros; William B Kannel; Thomas J Wang; Patrick T Ellinor; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

10.  Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study.

Authors:  Mariana S Parahuleva; Sandip Kanse; Hans Hölschermann; Kirila Zheleva; Daniel Zandt; Michael Worsch; Behnoush Parviz; Norbert Güttler; Harald Tillmanns; Andreas Böning; Ali Erdogan
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.